<p><strong>CHAPTER 2: DISORDERS OF THE LIVER</strong></p><p><strong>8. Amoebic Liver Access</strong></p><p>Amoebic liver abscess is a collection of typically brownish coloured fluid in the liver, occurring often as a single mass in the right lobe and a complication of intestinal infection with Entamoeba histolytica. Lung, heart and brain infections are uncommon sequelae. Occasionally, pyogenic abscesses may have a similar clinical presentation.</p><p>Treatment of amoebic abscesses should be initiated with a tissue agent active against the trophozoite form followed by a luminal agent to eliminate intra-luminal cysts.</p><p><strong>CAUSES</strong></p><ul><li><i>Entamoeba histolytica</i></li></ul><p><strong>SYMPTOMS</strong></p><ul><li>Right upper abdominal pain referable to the epigastrium, right chest or right shoulder</li><li>Fever</li><li>Malaise</li><li>Sweats</li><li>Cough</li><li>Hiccups</li><li>Anorexia</li><li>Weight loss</li><li>Jaundice (uncommon)</li><li>Concurrent diarrhoea (less than one-third of patients)</li></ul><p>&nbsp;</p><p><strong>SIGNS</strong></p><ul><li>Large tender liver</li><li>Tenderness and/or bulging at right intercostal spaces</li><li>Jaundice</li><li>Dullness to percussion on the right lower chest zones with basal crepitations</li><li>Amoebic empyema following extension into the chest cavity</li><li>Peritonitis (uncommon)</li></ul><p>&nbsp;</p><p><strong>INVESTIGATIONS</strong></p><ul><li>Abdominal ultrasound</li><li>Chest X-ray</li><li>FBC</li><li>ESR</li><li>Stool examination</li><li>Abdominal CT scan</li><li>Serology (amoebic antibodies)</li><li>&nbsp;</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To eradicate Entamoeba histolytica infection</li><li>To prevent further destruction of liver tissue</li><li>To prevent further complications (e.g. rupture of abscess into pleural, pericardial or peritoneal space)</li></ul><p>&nbsp;</p><p><strong>Non-pharmacological treatment</strong></p><ul><li>Therapeutic aspiration may be required in patients with poor response to therapy</li></ul><p>&nbsp;</p><p><strong>Pharmacological treatment</strong></p><p><strong>1st Line Treatment&nbsp;</strong></p><p>Evidence Rating: [A]</p><p>• &nbsp;Metronidazole, oral,</p><p><strong><u>Adults</u></strong></p><p>&nbsp; 800 mg 8 hourly for 10 days (tissue agent)</p><p><strong><u>Children</u></strong></p><p>&nbsp; 15 mg/kg 8 hourly for 10 days (tissue agent)</p><p><strong>Then</strong></p><p>• &nbsp;Diloxanide furoate, oral,</p><p><strong><u>Adults</u></strong></p><p>&nbsp; 500 mg 8 hourly for 10 days (luminal agent)</p><p><strong><u>Children</u></strong></p><p>&nbsp; 6-8 mg/kg 8 hourly for 10 days (luminal agent)</p><p><strong>2nd Line Treatment&nbsp;</strong></p><p>Evidence Rating: [A]</p><p>• &nbsp;Tinidazole, oral,</p><p><strong><u>Adults</u></strong></p><p>&nbsp; &nbsp;2 g once daily for 5 days (tissue agent)</p><p><strong><u>Children</u></strong></p><p>&nbsp; &nbsp;&gt;3 years; 50 mg/kg (max. 2 g) once daily for 5 days (tissue agent)</p><p><strong>Then</strong></p><p>• &nbsp;Paromomycin, oral,</p><p><strong><u>Adults</u></strong></p><p>&nbsp; 8-10 mg/kg 8 hourly for 7 days (luminal agent)</p><p><strong><u>Children</u></strong></p><p>&nbsp; 8-10 mg/kg 8 hourly for 7 days (luminal agent)</p><p>&nbsp;</p><p><strong>REFERRAL CRITERIA</strong></p><p>&nbsp;Patients with abscesses that are large or not responding to treatment will need to be referred to a specialist.</p>